Cancer-related fatigue
Conditions
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Pathologically or cytologically diagnosed patients with unresectable stage IIIb-IV non-small cell lung cancer 2. The estimated survival time is more than 3 months, ECOG PS=4.
Exclusion criteria
Exclusion criteria: 1. Any situation that may hinder the subject from completing the clinical trial process, including but not limited to serious, uncontrollable organic disease or infection, unstable angina, congestive heart failure, etc.; 2. Patients with severe liver and kidney dysfunction (serum creatinine >= 1.5 times ULN; ALT or AST >= 3 times ULN; bilirubin >= 1.5 times ULN); patients with symptomatic and difficult-to-control neurological, mental or mental disorders, Those whose thyroid function has not improved; 3. Those who have cognitive impairment and speech expression defects, and are unable to complete the questionnaire independently or with the assistance of others; 4. Patients with concurrent radiotherapy and chemotherapy; 5. Women who are pregnant or breastfeeding or planning to become pregnant; 6. Those with allergies or those who are known to be allergic to the ingredients contained in the test drug; 7. Those who are participating in a clinical trial within three months before the trial; 8. Patients with infectious diseases, such as active hepatitis B, AIDS, syphilis, etc.; 9. Patients with other malignant tumors; 10. Comply with the syndrome differentiation standard of yin deficiency and fire vigor in traditional Chinese medicine; 11. In addition to the above, patients judged by the investigator to be unsuitable to participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BFI scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Piper scale;Quality of life scale;Clinical symptom score;Exploratory index;Progression-free survival;Safety index; | — |
Countries
China
Contacts
Public ContactLin Lizhu
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed